Dr James T. Rutka of Toronto, Ontario is an internationally recognized physician, neurosurgeon, cancer researcher and educator. Dr Rutka is currently a professor in the Department of Surgery at the University of Toronto where he holds the Dan Family Chair in Neurosurgery and is Chairman of the Division of Neurosurgery. He is also Director of the Arthur and Sonia Labatt Brain Tumour Research Centre at the Hospital for Sick Children.
A Canadian Cancer Society funded researcher, Dr Rutka’s has a particular interest in brain cancer research. One of his recent projects uses a unique strategy that combines the study of genetics and epigenetics, to probe the origins of the most common malignant brain tumour in children, called medulloblastoma. Dr Rutka hopes that by studying the epigenetic factors, in combination with the genetic changes, it will lead to a better understanding of how the disease develops and may ultimately provide targets for new treatments.
“For many years, I have been a proud and grateful recipient of Canadian Cancer Society funds for my research work. I hope to bring my expertise in the areas of cancer research, clinical cancer care and healthcare administration to the Society’s Board of Directors so that the best decisions can be made regarding the funding of cancer research across Canada.”
A clinical trial led by the Society’s NCIC Clinical Trials group found that men with prostate cancer who are treated with intermittent courses of hormone therapy live as long as those receiving continuous therapy.